Imagine a researcher reviewing brain scans collected for a study on memory and aging. The study aims to understand how cognitive function changes over time, but one scan reveals an unusual abnormality that could indicate a serious medical condition. The finding has nothing to do with the original research question, and the participant has not reported any related symptoms. Suddenly, the researcher faces an important decision: Should the participant be informed, and how should that conversation take place?
Unexpected health findings, often called incidental findings, can arise during medical imaging, genetic testing, laboratory investigations, and other research procedures. Some may reveal previously unknown health conditions, while others suggest possible risks that require further investigation. According to Wolf et al. (2008), incidental findings create ethical challenges because researchers must decide whether the information is sufficiently important to disclose and how to manage the possible consequences. Although sharing a finding may help a participant obtain timely medical care, communicating uncertain information can cause unnecessary distress.
These situations remind researchers that their responsibilities extend beyond collecting data and answering research questions. A participant may have agreed to contribute information to a scientific study without expecting to receive personal medical results. Researchers must therefore consider the participant’s preferences, the reliability of the finding, and the potential consequences of disclosure. These considerations are important during Institutional Review Board (IRB) oversight, where the protection of research participants remains a central responsibility. Whether a study is reviewed by an institutional committee or an independent IRB, researchers should establish appropriate procedures before unexpected findings arise.
The challenge is not simply deciding whether to share information. Researchers must determine whether a finding is clinically meaningful, who should interpret it, and what support participants may need afterward. Effective IRB review can help investigators anticipate these responsibilities during study planning. Understanding how to move responsibly from discovery to disclosure is therefore essential for protecting participants and maintaining trust in research.
I. Understanding Unexpected Health Findings and Their Clinical Significance
Unexpected findings do not all carry the same meaning or require the same response. Some indicate potentially serious health concerns, while others represent uncertain observations that may have little medical importance. Before researchers decide whether disclosure is appropriate, they must understand what has been discovered and how confidently the information can be interpreted.
What Counts as an Unexpected Health Finding?
An unexpected health finding is information discovered during research that falls outside the study’s original objectives but may have implications for a participant’s health. For example, a cardiovascular study might reveal an unusual heart rhythm, while genetic research examining inherited characteristics could identify a variant associated with an unrelated medical condition. Similar discoveries can occur during neurological assessments, blood testing, and imaging studies. The defining feature is that the information was not the primary purpose of the investigation.
According to Wolf et al. (2008), incidental findings can arise across different research methods and may create responsibilities that investigators did not originally anticipate. The authors emphasize the importance of developing appropriate procedures for identifying and managing such discoveries. The Presidential Commission for the Study of Bioethical Issues (2013) highlights that researchers should anticipate the possibility of incidental findings and establish clear policies for handling them. During IRB approval, investigators should therefore explain whether their procedures are likely to reveal additional health information and how potentially important discoveries will be addressed.
Distinguishing Clinically Significant Findings From Uncertain Results
Not every unusual research result indicates a medical condition requiring treatment. A genetic variation may have an uncertain relationship with disease, while an imaging abnormality may reflect a harmless anatomical difference or an error produced during data collection. Researchers should avoid treating every unexpected observation as a confirmed diagnosis. Doing so may lead participants to experience unnecessary anxiety or pursue medical procedures that are not justified by the available evidence.
Fabsitz et al. (2010) emphasize that decisions about returning individual research findings should consider analytical validity, clinical significance, and the possibility of meaningful medical intervention. Their recommendations distinguish findings with established health implications from results whose significance remains uncertain. For researchers, this means determining whether a result is reliable, whether it indicates a meaningful health concern, and whether knowing about it could benefit the participant. An external IRB may evaluate whether the study includes appropriate assessment procedures, although interpreting the medical significance of a finding should involve qualified clinical professionals.
Why the Research Setting Matters
Research results are not always produced under the same conditions as clinical diagnostic results. A research laboratory may use experimental equipment, exploratory methods, or procedures designed to investigate scientific questions rather than diagnose disease. Consequently, an observation that is useful for research may require additional testing before it can support medical decisions. Researchers should recognize this distinction when deciding whether and how to communicate unexpected findings.
According to the National Academies of Sciences, Engineering, and Medicine (2018), decisions about returning individual research results should account for their reliability, potential value, and the conditions under which they were generated. The report recommends establishing institutional systems that support appropriate evaluation and communication. Researchers seeking IRB services should therefore prepare protocols that distinguish preliminary observations from findings requiring clinical attention. Investigators who need to find an IRB should consider whether the reviewing organization has experience evaluating studies that may produce clinically relevant health information.
II. Ethical Responsibilities Before Disclosing Unexpected Findings
Discovering an unexpected finding does not automatically mean that researchers should disclose it immediately. The ethical question is whether communicating the information would serve the participant’s interests while respecting personal preferences and avoiding unnecessary harm. Researchers must consider both the possible benefits of disclosure and the consequences of sharing information that may be incomplete or difficult to interpret.
Balancing the Duty to Inform With the Risk of Harm
Researchers may feel obligated to inform participants whenever a study reveals a possible health concern. This response is understandable, especially when early medical attention could prevent serious illness or improve treatment outcomes. However, immediate disclosure is not always the most appropriate decision. An uncertain result may lead someone to believe they have a serious disease when further investigation could show that the observation was incorrect or medically insignificant.
According to Wolf et al. (2008), incidental findings should be evaluated according to their potential clinical importance rather than managed through a single disclosure rule. Findings suggesting a serious and actionable health risk may justify prompt communication, while uncertain findings may require additional professional assessment. The Presidential Commission for the Study of Bioethical Issues (2013) emphasizes the importance of considering the potential benefits and harms associated with disclosure. A human subject review board can assess whether the proposed procedures adequately address these competing responsibilities and provide reasonable protections for participants.
Respecting Participants’ Right to Know or Not Know
Participants may have different preferences about receiving unexpected health information. Some want to know about possible medical conditions so they can seek treatment, make lifestyle changes, or discuss risks with family members. Others may prefer not to receive information about uncertain genetic risks or conditions for which no effective treatment exists. Researchers should respect these differences rather than assume that every participant wants access to every result.
Bredenoord et al. (2011) explain that returning individual genetic research findings requires careful consideration of participant autonomy, clinical relevance, and the responsibilities of researchers. Their discussion highlights why disclosure policies should account for participants’ preferences while recognizing that some findings may raise particularly important health concerns. The National Academies of Sciences, Engineering, and Medicine (2018) recommends incorporating participant preferences into policies governing the return of research results. During IRB review, ethics committees can examine whether informed consent materials adequately explain the possibility of unexpected findings and allow participants to express meaningful preferences about receiving them.
Preparing Researchers for Ethical Disclosure Decisions
Researchers should not be expected to make difficult disclosure decisions without appropriate guidance. Managing unexpected findings may require collaboration among principal investigators, clinicians, genetic counselors, laboratory specialists, and research ethics professionals. Each contributes expertise that helps the research team understand the finding and determine an appropriate response. Establishing these responsibilities before recruitment can prevent confusion when potentially important health information emerges.
According to Richardson and Belsky (2004), researchers may have responsibilities concerning participants’ healthcare needs that extend beyond the immediate scientific objectives of a study. Their ethical framework considers factors such as the researcher’s relationship with participants, the needs identified during research, and the resources available to assist. These considerations reinforce the importance of professional preparation. Appropriate IRB training can help investigators understand their responsibilities, while IRB training for students can introduce emerging researchers to ethical questions that arise when scientific activities reveal personal health concerns.
III. From Discovery to Disclosure: A Practical Approach for Researchers
Understanding ethical responsibilities is important, but researchers need a practical process for responding when unexpected information appears. Without established procedures, investigators may delay important decisions, communicate findings prematurely, or struggle to identify who should take responsibility (Beddoe & Cooner, 2025). A well-prepared research team should know how to assess a finding, determine whether disclosure is appropriate, communicate responsibly, and arrange suitable follow-up.
Establishing a Clear Process for Reviewing and Confirming Findings
The first step after identifying an unexpected finding is to determine whether the observation is reliable and warrants further investigation. Researchers should document how the finding was discovered, review the procedure that produced it, and consider whether technical limitations could explain the result. For example, an unusual laboratory measurement may reflect specimen handling problems rather than an underlying medical condition. An abnormality observed during research imaging may require evaluation by a qualified radiologist before its clinical implications can be understood.
According to Fabsitz et al. (2010), researchers should establish procedures for evaluating individual findings before deciding whether they should be returned to participants. Their recommendations emphasize the importance of expert assessment and clear criteria for determining clinical significance. A practical approach involves identifying qualified professionals who can review findings and recommend whether additional clinical confirmation is necessary. Researchers should describe these procedures in their protocols so that IRB approval is based on a clear understanding of how unexpected discoveries will be managed.
Once a finding has been assessed, the research team should determine how quickly a response is needed. Information suggesting an immediate threat to health may require urgent communication, while a finding associated with a possible long-term condition may allow time for additional assessment. Researchers should establish criteria for prioritizing these situations rather than relying entirely on individual judgment. An external IRB can evaluate the proposed response procedures and identify areas where the protocol requires clearer responsibilities or additional safeguards.
Developing a Disclosure Decision Pathway
A disclosure decision pathway identifies the steps researchers should follow after discovering potentially important health information. It should explain who receives the initial report, who evaluates the finding, who decides whether disclosure is appropriate, and who communicates with the participant. The pathway should address disagreements among professionals and situations where additional medical evaluation is necessary. Clearly assigning these responsibilities supports consistency and accountability throughout the process.
The National Academies of Sciences, Engineering, and Medicine (2018) recommends that research institutions establish policies and systems for managing the return of individual research results. These arrangements should reflect the nature of the study, the potential importance of findings, and the resources available to researchers. Investigators preparing protocols for a human subject review board should explain how decisions will be documented and whether qualified professionals will be available when needed. Researchers who need to find an IRB should consider whether the reviewing organization can appropriately assess the ethical challenges associated with unexpected health findings.
Communicating Sensitive Health Information Responsibly
Once a finding has been assessed and disclosure is considered appropriate, researchers must decide how to communicate the information. Receiving unexpected health news can be unsettling, particularly when participants entered the study without expecting to learn about their personal medical condition. A short email containing unfamiliar medical terminology may create confusion or unnecessary fear. Communication should therefore be planned carefully, with attention to the participant’s understanding and emotional well-being.
Researchers should explain what was observed, why the information may matter, and what remains uncertain. They should clearly distinguish between a research observation and a confirmed medical diagnosis. For example, rather than telling a participant that a research scan shows a particular disease, the researcher might explain that the scan revealed an observation requiring assessment by a healthcare professional. According to the National Academies of Sciences, Engineering, and Medicine (2018), returning individual results should involve communication practices that help participants understand the meaning and limitations of the information provided.
Choosing an Appropriate Communication Method
The method used to disclose unexpected findings should reflect the sensitivity, urgency, and potential consequences of the information. Some findings may be discussed through a scheduled telephone or video consultation, while others may require an in-person conversation with a qualified healthcare professional. Researchers should consider whether participants have a private setting in which to receive sensitive information. Where possible, participants should have opportunities to ask questions and receive written explanations of recommended next steps.
Communication planning should account for differences in language, health literacy, and accessibility needs. An explanation may be medically accurate but still fail to help a participant understand what the finding means. Appropriate IRB training can prepare research staff to recognize these communication challenges and understand when clinical professionals should lead sensitive discussions. Through IRB review, committees can assess whether proposed communication procedures are appropriate for the study population and the types of findings that may arise.
Arranging Clinical Follow-Up and Documenting Disclosure
Informing participants about unexpected health findings does not necessarily resolve the research team’s responsibilities. Some individuals may require additional testing, specialist consultation, or assistance identifying suitable healthcare providers. However, researchers should avoid promising diagnostic or treatment services that their study cannot provide. The disclosure process should clearly explain what support is available through the research project and which steps require ordinary clinical care.
Richardson and Belsky (2004) explain that researchers’ responsibilities concerning participants’ healthcare needs depend partly on the circumstances of the research relationship and the resources available. Their framework provides a useful basis for considering what assistance may reasonably be expected after an unexpected finding emerges. Wolf et al. (2008) emphasize that planning for incidental findings should include consideration of appropriate follow-up responsibilities. During IRB approval, reviewers may assess whether the proposed referral arrangements are realistic and proportionate to the anticipated findings.
Protecting Confidentiality and Maintaining Accurate Records
Unexpected health findings may involve information that participants consider highly sensitive. Genetic findings, for example, can raise concerns about privacy, family relationships, and future healthcare decisions. Researchers should therefore limit access to identifiable information and use approved, secure communication methods. Results should not be shared with family members or other third parties without an appropriate legal or ethical basis.
Documentation is equally important because it creates a record of how the research team responded to the discovery. Investigators should record the initial observation, professional assessments, reasons for disclosure decisions, communication methods, and any follow-up recommendations. These records should be maintained according to approved research procedures and applicable confidentiality requirements. Researchers using IRB services can seek guidance on developing documentation procedures, while human-subject research training can strengthen research staff members’ understanding of privacy and reporting responsibilities.
Conclusion
Unexpected health findings remind researchers that participation in a study can have consequences beyond answering the original research question. A discovery made during routine data collection may provide an opportunity for timely medical attention, but it can create uncertainty, anxiety, and difficult personal decisions. Researchers must therefore approach disclosure as a planned ethical responsibility rather than an unexpected administrative task. From evaluating a potentially significant finding to arranging appropriate communication and follow-up, every decision should prioritize participant welfare while recognizing the limitations of research-generated information.
Responsible preparation begins before the first participant enrolls. Researchers should establish procedures for assessing findings, explain disclosure possibilities during informed consent, identify qualified professionals who can provide clinical interpretation, and develop realistic referral pathways. Appropriate IRB training for students and experienced investigators can strengthen awareness of these responsibilities, while ongoing IRB training can help research teams maintain ethical practices as research methods evolve. When these safeguards are incorporated into study design, researchers are better prepared to respond responsibly when unexpected discoveries occur.
For researchers preparing studies that may reveal unexpected health information, BeyondBound IRB provides IRB services designed to support ethical research planning and participant protection. Whether investigators need guidance from an external IRB, assistance preparing for IRB review, or support understanding requirements for IRB approval, early engagement can help identify potential concerns before they affect participants. Through IRB Heart, researchers and students can strengthen their understanding of research ethics through practical human-subject research training.
Responsible research does not end when investigators discover something scientifically important. It requires considering what that discovery means for the person who contributed to the study. By preparing carefully, communicating respectfully, and seeking appropriate ethical guidance, researchers can move from discovery to disclosure in ways that protect participants and strengthen trust in research.
References
Beddoe, L., & Cooner, T. S. (2025). Dealing with the unexpected in research. In Handbook of research methods in social work (pp. 431-440). Edward Elgar Publishing. https://doi.org/10.4337/9781035310173.00045
Bredenoord, A. L., Kroes, H. Y., Cuppen, E., Parker, M., & van Delden, J. J. M. (2011). Disclosure of individual genetic data to research participants: The debate reconsidered. Trends in Genetics, 27(2), 41–47. https://doi.org/10.1016/j.tig.2010.11.004
Fabsitz, R. R., McGuire, A., Sharp, R. R., Puggal, M., Beskow, L. M., Biesecker, L. G., Bookman, E., Burke, W., Burchard, E. G., Church, G., Clayton, E. W., Eckfeldt, J. H., Fernandez, C. V., Fisher, R., Fullerton, S. M., Gabriel, S., Gachupin, F., James, C., Jarvik, G. P., … Burke, G. L. (2010). Ethical and practical guidelines for reporting genetic research results to study participants: Updated guidelines from a National Heart, Lung, and Blood Institute working group. Circulation: Cardiovascular Genetics, 3(6), 574–580. https://doi.org/10.1161/CIRCGENETICS.110.958827
National Academies of Sciences, Engineering, and Medicine. (2018). Returning individual research results to participants: Guidance for a new research paradigm. The National Academies Press. https://doi.org/10.17226/25094
Presidential Commission for the Study of Bioethical Issues. (2013). Anticipate and communicate: Ethical management of incidental and secondary findings in the clinical, research, and direct-to-consumer contexts. https://bioethicsarchive.georgetown.edu/pcsbi/node/3183.html
Richardson, H. S., & Belsky, L. (2004). The ancillary-care responsibilities of medical researchers: An ethical framework for thinking about the clinical care that researchers owe their subjects. Hastings Center Report, 34(1), 25–33. https://doi.org/10.2307/3528248
Wolf, S. M., Lawrenz, F. P., Nelson, C. A., Kahn, J. P., Cho, M. K., Clayton, E. W., Fletcher, J. G., Georgieff, M. K., Hammerschmidt, D., Hudson, K., Illes, J., Kapur, V., Keane, M. A., Koenig, B. A., LeRoy, B. S., McFarland, E. G., Paradise, J., Parker, L. S., Terry, S. F., … Wilfond, B. S. (2008). Managing incidental findings in human subjects research: Analysis and recommendations. The Journal of Law, Medicine & Ethics, 36(2), 219–248. https://doi.org/10.1111/j.1748-720X.2008.00266.x